The spread of COVID-19 has presented the global healthcare and life sciences sectors with unprecedented challenges. At the same time, it has underscored how quickly the industry can pivot to boost capacity in critical areas and support significant rapid changes in demand for technology and devices around the world.
As well as the immediate pressures on governments and healthcare services, COVID-19 has also unearthed important questions for the future of medical devices and technology. For instance, in years to come, which medical devices will be regarded as ‘critical’? How will this affect the supply chains of the companies producing these devices? What government regulations and requirements will exist for safeguarding domestic populations?
The opportunities and challenges that we discuss in this paper are designed to provide a rough guide to success in the medical technology space. At Alvarez & Marsal, we are leveraging our specialisms in operational transformation, transaction advisory and supply chain to guide leading enterprises through difficult times. We look forward to observing and contributing as the medical technology sector continues to develop.
Click here to read the article.
The Future of Utility Rate Design
July 15, 2026
In this article, A&M's Energy & Natural Resources team explores how utility rate design is evolving to balance infrastructure investment, customer affordability, and long-term grid resilience, and examines the emerging regulatory tools shaping the future of the electric utility industry.
June 2026 Debt Market Update
July 15, 2026
A&M’s latest Debt Market Update highlights key developments shaping private credit, leveraged lending, and macro-economic conditions.
Primera Resolución de modificaciones a la Resolución Miscelánea Fiscal 2026
July 15, 2026
Recientemente el Servicio de Administración Tributaria (SAT) dio a conocer con la Primera Resolución de modificaciones a la Resolución Miscelánea Fiscal 2026 (RMF) una facilidad para las instituciones del sistema financiero que efectúen pagos de intereses a fideicomisos no empresariales emisores de certificados bursátiles fiduciarios de proyectos de inversión, comúnmente conocidos como CERPIS.
Germany: First Administrative Guidance on the German Tax Treatment of Hurdle Shares
July 15, 2026
Germany’s first administrative guidance provides welcome clarity on the tax treatment of hurdle shares. It confirms that properly structured management equity can remain tax-efficient, provided valuation and implementation are robust.
